SCM
NPCE icon

Soleus Capital Management’s Neuropace NPCE Stock Holding History

Soleus Capital Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.3M Sell
2,911,122
-21,085
-0.7% -$339K 1.59% 16
2026
Q1 		$38.6M Buy
2,932,207
+228,999
+8% +$3.44M 1.56% 19
2025
Q4 		$41.7M Sell
2,703,208
-254,749
-9% -$3.41M 1.54% 17
2025
Q3 		$30.5M Buy
2,957,957
+645,000
+28% +$6.08M 1.54% 23
2025
Q2 		$25.8M Sell
2,312,957
-295,211
-11% -$3.69M 1.71% 19
2025
Q1 		$32.1M Buy
2,608,168
+175,000
+7% +$2.19M 2.31% 12
2024
Q4 		$27.2M Hold
2,433,168
– – 1.71% 18
2024
Q3 		$17M Hold
2,433,168
– – 1.31% 27
2024
Q2 		$18.4M Hold
2,433,168
– – 1.62% 23
2024
Q1 		$32.1M Hold
2,433,168
– – 2.38% 9
2023
Q4 		$25.1M Sell
2,433,168
-33,037
-1% -$263K 2.78% 14
2023
Q3 		$24M Sell
2,466,205
-9
-0% -$53 2.21% 13
2023
Q2 		$11.1M Buy
2,466,214
+37,500
+2% +$170K 1.23% 23
2023
Q1 		$11.3M Buy
2,428,714
+59,711
+3% +$229K 1.17% 27
2022
Q4 		$3.53M Buy
2,369,003
+35,000
+1% +$77.8K 0.51% 46
2022
Q3 		$8.75M Hold
2,334,003
– – 1.19% 26
2022
Q2 		$11.6M Buy
2,334,003
+10,000
+0.4% +$66K 1.8% 19
2022
Q1 		$19.1M Buy
2,324,003
+15,000
+0.6% +$129K 2.46% 12
2021
Q4 		$23.3M Buy
2,309,003
+638,867
+38% +$8.3M 2.33% 11
2021
Q3 		$26.5M Buy
1,670,136
+285,749
+21% +$6M 4.13% 6
2021
Q2 		$32.9M Buy
+1,384,387
New +$32.1M 5.06% 4

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Soleus Capital Management's NPCE Position: Q2 2026 in Review

Soleus Capital Management reduced its Neuropace (NPCE) stake by 0.72% in Q2 2026, selling an estimated $339K and leaving 2,911,122 shares worth $46.3M. The position accounts for 1.59% of the portfolio, ranked #16.

Soleus Capital Management first reported a position in NPCE in Q2 2021 and has held it in 21 quarters since. 112 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Soleus Capital Management held 2,911,122 shares of Neuropace worth $46.3M as of Q2 2026.
  • Soleus Capital Management sold 21,085 Neuropace shares in Q2 2026, an estimated $339K.
  • Neuropace made up 1.59% of Soleus Capital Management's portfolio in Q2 2026, its #16 holding.
  • Soleus Capital Management first reported a position in Neuropace in Q2 2021 and has held it in 21 quarters since.
  • 112 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.